George Tonn
Head of DMPK

After receiving his PhD from the University of British Columbia, George has worked in the Pharma/Biotech industry for the last 30+ years in companies ranging from start-ups to large Pharma. He has gained experience working in multiple therapeutic areas (metabolic, oncology, inflammation, anti-infectives and CNS), and with multiple therapeutic modalities (small molecules, peptides, fusion proteins, and antibodies).

For the last 5+ years, George has worked as a consultant helping clients develop strategies to discover and advance agents with suitable pharmacokinetic and ADME (absorption, distribution, metabolism and excretion) properties to achieve their therapeutic objectives.